pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-302b |
Genomic Coordinates | chr4: 112648485 - 112648557 |
Description | Homo sapiens miR-302b stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-302b-5p | ||||||||||||||||||||||||||||||
Sequence | 11| ACUUUAACAUGGAAGUGCUUUC |32 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PIK3C2B | ||||||||||||||||||||
Synonyms | C2-PI3K | ||||||||||||||||||||
Description | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | ||||||||||||||||||||
Transcript | NM_002646 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PIK3C2B | |||||||||||||||||||||
3'UTR of PIK3C2B (miRNA target sites are highlighted) |
>PIK3C2B|NM_002646|3'UTR 1 GCCCAGCAGAGCCACCACCCAGCATCCCAGGCTGGTGGCAGGAGCTGGGGGAGAGGACTCTCCCCTGTGAGACTCCTCCT 81 TGTGAAGGGCCAGGGCCCTGGGCAGGCCTCCAGCTCGGTCCAGGTGATTCTGGCCTCTGTGGTAGGAGGCAGGGAGAGTA 161 AGACATGCTCTGCTGTCTCTTCCTCTGGAGACTGAACTTGGGTTGGTTGTGATGAGCAGCCCCTTGGAGGCTGTGAGGTT 241 GCAGCAAAGTTTTAAGTTTACCTTGTGTCAAGGGAGCAATGCTTGGTTTGGGGAGTGTGTGGGGTGGGCTGTATGAAGTA 321 GCATTTTGGGGGTGGGTGGGTGGATATCTTAATTTTTATTTTTAAAAAATGAAATAGTGATGTTGTCCTAACTGGGACAG 401 GAAGCCTTGCGAGAAGGGACGTACCTATGCCCCAGAAGGCAAGAGAGGAAGACTATTTGGACTTTTTGTATGATTAAGGT 481 TCTTATTGGACTTTTCCCTAGGTTTTTTTTTTTTGTTATTGTTGTTGTTGTTTCGTTTTCTAGCTATAGGAACTATCTGG 561 GGAGGGGCCCAGTGGGTCCTCGGCCAGAGCCCTCTCTAAGGACAGGTTGGGGAGGGTTGGGGAGGGCTGCCTGTGCTGGA 641 CTGAGGCTTGTGCCACTGGGCCTTTCTGATTTTGCCTCCAAAGGAGAGCGCTGTGATACCTACATGTGTAAGGAAGGGCC 721 TTCCGTATTGGGGTTCTGCCAAGGACCCGTATTCAGGGACCCATGCTCTTTTGGGGGGACTTTTCCTCTTGTCTTCCCTA 801 CTTTATTAGGACTTGCCCTGAATACCATTTTCTACCCCTTGCCCCTCCATTCTCCTGGCCCTTCTGGGGGTCAGCTGGTC 881 TCTATGAATATGCTGGGGGTGCTTCCCCATAGGTCTCTCCCTTCATTTGTCTCTGGTGGGACAAAATACTGACTCAGTCC 961 TTAGATGTAGTTTCACCCAAGAGCATCTTGGCCCTGGGAAGAGGTCCCTAGGCTGCAGATGCTACTGACTGCTTGCTAGG 1041 TAGCCTCTGGAAAGCATTCCCCATCCATCACTCCCCACTTCTTTCTGCTGTGCTGCTTCCCTCCCAAACTCCATTTCTGT 1121 CACCCTTTTTATAAGACTTTTCCTCATTCTGTGGGGCCATAAACCTATTTAGTCTGGAGCCAAAGGGATGCCCTATCTGA 1201 AGGAAAGGGGCATGGGGTGGGGGATTCCATCAAAACTGTTGTTTTTTGCCCCATGATTTTTCTTTGGTCAGTAGGAGGCT 1281 GGATTGGAGTGGTGATTATTCCCCTGGAGCTAAGCTCAGGAGCCCGAAGGGAGAGACTGAGACTGACTCCCTTATCTCTT 1361 CATATTCTTTATTCCCTACCAGATGGATTTTTTTTTTTTTTTTTGGAGACGGAGTCTCGCCCTGTCGCCAGGCTGGAGTG 1441 TAGTGGCATGATCTCGACTCACTGCAAAATCTGCCTCCCGGGTTCAAGCGATTCTCCTACCTCAGCCTCCCGAGTAGCTG 1521 GGATTACAGGCATGTGCCACCACGCCAAGCTAATTTTTGTATTTTTAGTAGAGACGGGGTTTCACCATGTTGGCCAGGAT 1601 GGTCTCGATCTCTTGACCTCGTGATCTGCCTGCCTTGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACCATGCCC 1681 CGCCCCAGATGGATTTTACATTTGCTCTTTTGTGTTTCGCTCCAAAGGGTTGTCTTCCTCGCCAAAAGGAGGGAGGGACT 1761 TTGAATTTGATATGAATCTTTAAAACCAGAATTGGCTGGATATTTCCCATGATTGGGAAAAGAGTGAAATGAGGACATTC 1841 TGTAAACTGTCCCTCCCTAATTCCAAGGATCAGAAACTCCCCGTTTTGCTGACTCATTCCATAACTGGAGAAAGAAGCTC 1921 CATTGACCGAAGCCACAGGGCAGCATGGAAGTTTAAATTTTCTCTAAAATTAAAATGCCAAGGATAAAGCTGGCTGCTTC 2001 CAGGAGGGGGAAGAGGAGTGGGGAGTGGGCGGTGAAACTTTTCCAGATGAACGGACCATAAATGTGTTACTGGCTTTGTG 2081 CCTGTAGCTCATTTTATTATGACCTATATGCTCCTGATTTAAAGAGATCTGTGTACTGTTTACTTCCCACTTCCCAGAAT 2161 CCCTTGTATCTCCTTTCTCGGGAATTGTATTTTCTAATAAATGACATTTGAGAAAAAAATGA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000367187.3 | 3UTR | AUUUAAAGAGAUCUGUGUACUGUUUACUUCCCACUUCCCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
109 hsa-miR-302b-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT088427 | LCLAT1 | lysocardiolipin acyltransferase 1 | 2 | 4 | ||||||||
MIRT142406 | TNRC6A | trinucleotide repeat containing 6A | 2 | 2 | ||||||||
MIRT162006 | TFRC | transferrin receptor | 2 | 2 | ||||||||
MIRT170893 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT203348 | CCNT2 | cyclin T2 | 2 | 4 | ||||||||
MIRT207353 | TGOLN2 | trans-golgi network protein 2 | 2 | 2 | ||||||||
MIRT208232 | CNBP | CCHC-type zinc finger nucleic acid binding protein | 2 | 4 | ||||||||
MIRT214733 | HSPA9 | heat shock protein family A (Hsp70) member 9 | 2 | 2 | ||||||||
MIRT254842 | NUP50 | nucleoporin 50 | 2 | 2 | ||||||||
MIRT257285 | FOXC1 | forkhead box C1 | 2 | 2 | ||||||||
MIRT338890 | LLPH | LLP homolog, long-term synaptic facilitation | 2 | 2 | ||||||||
MIRT400032 | USP37 | ubiquitin specific peptidase 37 | 2 | 2 | ||||||||
MIRT404031 | ATP9A | ATPase phospholipid transporting 9A (putative) | 2 | 8 | ||||||||
MIRT405843 | EIF2S1 | eukaryotic translation initiation factor 2 subunit alpha | 2 | 2 | ||||||||
MIRT445847 | FPGT | fucose-1-phosphate guanylyltransferase | 2 | 2 | ||||||||
MIRT446350 | EML6 | echinoderm microtubule associated protein like 6 | 2 | 2 | ||||||||
MIRT446649 | BTBD7 | BTB domain containing 7 | 2 | 2 | ||||||||
MIRT447925 | SCRN1 | secernin 1 | 2 | 2 | ||||||||
MIRT448575 | PLCG1 | phospholipase C gamma 1 | 2 | 2 | ||||||||
MIRT463616 | ZBTB33 | zinc finger and BTB domain containing 33 | 2 | 4 | ||||||||
MIRT465782 | TMOD3 | tropomodulin 3 | 2 | 2 | ||||||||
MIRT470261 | PRR14L | proline rich 14 like | 2 | 2 | ||||||||
MIRT471090 | PIK3C2B | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | 2 | 2 | ||||||||
MIRT475612 | HMGB1 | high mobility group box 1 | 2 | 2 | ||||||||
MIRT476824 | FNDC3A | fibronectin type III domain containing 3A | 2 | 2 | ||||||||
MIRT483107 | TYRP1 | tyrosinase related protein 1 | 2 | 10 | ||||||||
MIRT500537 | XPO4 | exportin 4 | 2 | 2 | ||||||||
MIRT502525 | EPHA2 | EPH receptor A2 | 2 | 4 | ||||||||
MIRT510989 | PER1 | period circadian clock 1 | 2 | 4 | ||||||||
MIRT512540 | ZNF793 | zinc finger protein 793 | 2 | 4 | ||||||||
MIRT513868 | HOXA5 | homeobox A5 | 2 | 2 | ||||||||
MIRT520756 | TFDP1 | transcription factor Dp-1 | 2 | 6 | ||||||||
MIRT524304 | CTC1 | CST telomere replication complex component 1 | 2 | 8 | ||||||||
MIRT526306 | JAKMIP2 | janus kinase and microtubule interacting protein 2 | 2 | 2 | ||||||||
MIRT526378 | LSAMP | limbic system-associated membrane protein | 2 | 2 | ||||||||
MIRT527438 | COL4A3 | collagen type IV alpha 3 chain | 2 | 2 | ||||||||
MIRT527511 | ZNF134 | zinc finger protein 134 | 2 | 2 | ||||||||
MIRT528068 | HES2 | hes family bHLH transcription factor 2 | 2 | 2 | ||||||||
MIRT528367 | ZMYM1 | zinc finger MYM-type containing 1 | 2 | 4 | ||||||||
MIRT531804 | TFCP2L1 | transcription factor CP2 like 1 | 2 | 2 | ||||||||
MIRT532323 | DUSP4 | dual specificity phosphatase 4 | 2 | 2 | ||||||||
MIRT532431 | DHX33 | DEAH-box helicase 33 | 2 | 2 | ||||||||
MIRT534523 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT536660 | INIP | INTS3 and NABP interacting protein | 2 | 2 | ||||||||
MIRT538488 | CLOCK | clock circadian regulator | 2 | 2 | ||||||||
MIRT538593 | CDK6 | cyclin dependent kinase 6 | 2 | 2 | ||||||||
MIRT539706 | EIF3H | eukaryotic translation initiation factor 3 subunit H | 2 | 2 | ||||||||
MIRT540306 | GFPT1 | glutamine--fructose-6-phosphate transaminase 1 | 2 | 2 | ||||||||
MIRT546892 | PURA | purine rich element binding protein A | 2 | 2 | ||||||||
MIRT552738 | YRDC | yrdC N6-threonylcarbamoyltransferase domain containing | 2 | 2 | ||||||||
MIRT552781 | YIPF6 | Yip1 domain family member 6 | 2 | 2 | ||||||||
MIRT553742 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | 2 | 4 | ||||||||
MIRT553909 | SUMO2 | small ubiquitin-like modifier 2 | 2 | 2 | ||||||||
MIRT554540 | RRS1 | ribosome biogenesis regulator homolog | 2 | 2 | ||||||||
MIRT555319 | PPP2CB | protein phosphatase 2 catalytic subunit beta | 2 | 2 | ||||||||
MIRT555512 | PMEPA1 | prostate transmembrane protein, androgen induced 1 | 2 | 2 | ||||||||
MIRT556221 | MB21D2 | Mab-21 domain containing 2 | 2 | 2 | ||||||||
MIRT556292 | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 2 | 2 | ||||||||
MIRT556606 | LDOC1L | retrotransposon Gag like 6 | 2 | 4 | ||||||||
MIRT556901 | ISOC1 | isochorismatase domain containing 1 | 2 | 2 | ||||||||
MIRT557675 | GATA6 | GATA binding protein 6 | 2 | 2 | ||||||||
MIRT560198 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT560493 | BUB3 | BUB3, mitotic checkpoint protein | 2 | 2 | ||||||||
MIRT566069 | RCC2 | regulator of chromosome condensation 2 | 2 | 2 | ||||||||
MIRT568431 | GDNF | glial cell derived neurotrophic factor | 2 | 2 | ||||||||
MIRT570703 | FAM69A | family with sequence similarity 69 member A | 2 | 2 | ||||||||
MIRT571705 | RPL36A-HNRNPH2 | RPL36A-HNRNPH2 readthrough | 2 | 2 | ||||||||
MIRT573152 | ITGA9 | integrin subunit alpha 9 | 2 | 2 | ||||||||
MIRT574410 | TFAP2A | transcription factor AP-2 alpha | 2 | 2 | ||||||||
MIRT614823 | PVRL4 | nectin cell adhesion molecule 4 | 2 | 2 | ||||||||
MIRT616507 | COX7A2L | cytochrome c oxidase subunit 7A2 like | 2 | 2 | ||||||||
MIRT618301 | COL4A4 | collagen type IV alpha 4 chain | 2 | 2 | ||||||||
MIRT621188 | FAM153B | family with sequence similarity 153 member B | 2 | 2 | ||||||||
MIRT621594 | WT1 | Wilms tumor 1 | 2 | 2 | ||||||||
MIRT623814 | GGCX | gamma-glutamyl carboxylase | 2 | 2 | ||||||||
MIRT624407 | CCDC171 | coiled-coil domain containing 171 | 2 | 2 | ||||||||
MIRT625136 | CKAP2L | cytoskeleton associated protein 2 like | 2 | 2 | ||||||||
MIRT626121 | MRRF | mitochondrial ribosome recycling factor | 2 | 2 | ||||||||
MIRT626874 | AP3B1 | adaptor related protein complex 3 beta 1 subunit | 2 | 2 | ||||||||
MIRT627874 | PAN2 | PAN2 poly(A) specific ribonuclease subunit | 2 | 2 | ||||||||
MIRT633670 | FAM53B | family with sequence similarity 53 member B | 2 | 2 | ||||||||
MIRT634285 | SYAP1 | synapse associated protein 1 | 2 | 2 | ||||||||
MIRT640925 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT642028 | MYADM | myeloid associated differentiation marker | 2 | 2 | ||||||||
MIRT643031 | CHCHD7 | coiled-coil-helix-coiled-coil-helix domain containing 7 | 2 | 2 | ||||||||
MIRT646122 | SLC26A9 | solute carrier family 26 member 9 | 2 | 2 | ||||||||
MIRT646245 | SNAP47 | synaptosome associated protein 47 | 2 | 2 | ||||||||
MIRT652457 | TMEM2 | transmembrane protein 2 | 2 | 2 | ||||||||
MIRT657018 | KCNK5 | potassium two pore domain channel subfamily K member 5 | 2 | 2 | ||||||||
MIRT660586 | APP | amyloid beta precursor protein | 2 | 2 | ||||||||
MIRT664316 | CD209 | CD209 molecule | 2 | 2 | ||||||||
MIRT667113 | OLA1 | Obg like ATPase 1 | 2 | 2 | ||||||||
MIRT668773 | DCP2 | decapping mRNA 2 | 2 | 2 | ||||||||
MIRT698430 | TM4SF1 | transmembrane 4 L six family member 1 | 2 | 2 | ||||||||
MIRT700216 | REL | REL proto-oncogene, NF-kB subunit | 2 | 2 | ||||||||
MIRT710498 | CAPRIN1 | cell cycle associated protein 1 | 2 | 2 | ||||||||
MIRT711836 | AMOTL2 | angiomotin like 2 | 2 | 2 | ||||||||
MIRT713226 | GPR75 | G protein-coupled receptor 75 | 2 | 2 | ||||||||
MIRT714415 | TBC1D16 | TBC1 domain family member 16 | 2 | 2 | ||||||||
MIRT714490 | HSPA4 | heat shock protein family A (Hsp70) member 4 | 2 | 2 | ||||||||
MIRT715254 | F9 | coagulation factor IX | 2 | 2 | ||||||||
MIRT716250 | PALM2 | paralemmin 2 | 2 | 2 | ||||||||
MIRT717261 | BMPR2 | bone morphogenetic protein receptor type 2 | 2 | 2 | ||||||||
MIRT717730 | FGF1 | fibroblast growth factor 1 | 2 | 2 | ||||||||
MIRT719262 | CD44 | CD44 molecule (Indian blood group) | 2 | 2 | ||||||||
MIRT719398 | SLC15A4 | solute carrier family 15 member 4 | 2 | 2 | ||||||||
MIRT720653 | TMEM218 | transmembrane protein 218 | 2 | 2 | ||||||||
MIRT720777 | MSANTD3-TMEFF1 | MSANTD3-TMEFF1 readthrough | 2 | 2 | ||||||||
MIRT722059 | TMEFF1 | transmembrane protein with EGF like and two follistatin like domains 1 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|